Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Batenhorst

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
American Journal of Hospital Pharmacy|December 1, 1982
Risks of continuous narcotic infusionsR L Batenhorst, D A Graves
American Journal of Hospital Pharmacy|October 1, 1984
Role of pharmacy technicians on the cardiac-arrest teamK A Michael, R L Batenhorst
Clinical Pharmacy|January 1, 1984
Patient-controlled analgesia: dose increments and equianalgesic dosesD A Graves, T S Foster, R L Batenhorst
Drug Intelligence & Clinical Pharmacy|April 1, 1983
High-dose procainamide in chronic renal failureM B Bottorff, C S Kuo, R L Batenhorst
Clinical Pharmacy|July 1, 1983
Mechanisms and control of ventricular tachyarrhythmiasR L Batenhorst, M B Bottorff, C S Kuo
Clinical Pharmacy|January 1, 1982
Comparative bioavailability of chlorpropamide tablet and suspension formulationsR L Batenhorst, J A Bustrack, B A Bivins, et al.
Ophthalmology|May 1, 1989
The effect of caffeine on intraocular pressure in glaucoma patientsE J Higginbotham, H A Kilimanjaro, J T Wilensky, et al.
Clinical Pharmacy|January 1, 1985
Relationship between plasma morphine concentrations and pharmacologic effects in postoperative patients using patient-controlled analgesiaD A Graves, J M Arrigo, T S Foster, et al.
Journal of Clinical Pharmacology|November 1, 1993
Bioequivalence of a 17 beta-estradiol hydroxypropyl-beta-cyclodextrin complex in postmenopausal womenT J Hoon, M Y Dawood, F S Khan-Dawood, et al.
Chest|April 1, 1982
Treatment of refractory ventricular arrhythmias. High dose parenteral and oral bretylium tosylateJ W Noneman, R L Batenhorst, M R Jones, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
American Journal of Hospital Pharmacy|December 1, 1982
Risks of continuous narcotic infusionsR L Batenhorst, D A Graves
American Journal of Hospital Pharmacy|October 1, 1984
Role of pharmacy technicians on the cardiac-arrest teamK A Michael, R L Batenhorst
Clinical Pharmacy|January 1, 1984
Patient-controlled analgesia: dose increments and equianalgesic dosesD A Graves, T S Foster, R L Batenhorst
Drug Intelligence & Clinical Pharmacy|April 1, 1983
High-dose procainamide in chronic renal failureM B Bottorff, C S Kuo, R L Batenhorst
Clinical Pharmacy|July 1, 1983
Mechanisms and control of ventricular tachyarrhythmiasR L Batenhorst, M B Bottorff, C S Kuo
Clinical Pharmacy|January 1, 1982
Comparative bioavailability of chlorpropamide tablet and suspension formulationsR L Batenhorst, J A Bustrack, B A Bivins, et al.
Ophthalmology|May 1, 1989
The effect of caffeine on intraocular pressure in glaucoma patientsE J Higginbotham, H A Kilimanjaro, J T Wilensky, et al.
Clinical Pharmacy|January 1, 1985
Relationship between plasma morphine concentrations and pharmacologic effects in postoperative patients using patient-controlled analgesiaD A Graves, J M Arrigo, T S Foster, et al.
Journal of Clinical Pharmacology|November 1, 1993
Bioequivalence of a 17 beta-estradiol hydroxypropyl-beta-cyclodextrin complex in postmenopausal womenT J Hoon, M Y Dawood, F S Khan-Dawood, et al.
Chest|April 1, 1982
Treatment of refractory ventricular arrhythmias. High dose parenteral and oral bretylium tosylateJ W Noneman, R L Batenhorst, M R Jones, et al.
Pageof 3